阿扎丙宗治疗类风湿关节炎的临床评估
Clinical assessment of azapropazone in rheumatoid arthritis.
作者信息
Grennan D M, McLeod M, Watkins C, Dick W C
出版信息
Curr Med Res Opin. 1976;4(1):44-9. doi: 10.1185/03007997609109280.
PMID:770079
Abstract
Azapropazone was investigated in a 2-week double-blind clinical out-patient trial against placebo in 23 patients with definite rheumatoid arthritis. The drug was given at a dose of 1200 mg. per day before food. At this dose level the drug was shown to have an antirheumatic effect in terms of pain relief, articular tenderness and duration of morning stiffness.
摘要
在一项针对23名确诊类风湿性关节炎患者的为期两周的双盲临床门诊试验中，对阿扎丙宗与安慰剂进行了对比研究。该药以每日1200毫克的剂量在饭前服用。在这个剂量水平下，该药在缓解疼痛、关节压痛和晨僵持续时间方面显示出抗风湿作用。
Zotero 插件